Zimbabwe has rejected a major US health deal valued at 367 million US dollars (272 million pounds) spanning five years due to Washington's demand for confidential information.
This move became public following a internal memorandum from December was leaked, revealing that Head of State Emmerson Mnangagwa felt the deal was "lopsided".
A government spokesman has since clarified that the United States was seeking biological samples for scientific study and profit but was unwilling to share the benefits from any future medical innovations.
"We are forced to start the challenging and unfortunate process of scaling back our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had donated more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A medical body in Zimbabwe has urged continued talks to reach a agreement suitable to both sides so the nation's vital HIV treatment initiative can be sustained.
Wider Background
This development follows a comparable case in neighbouring Kenya, where a court suspended a similar deal with the US after legal challenges were filed about the security of citizens' health data.
After resuming the presidency last year, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
The agency had managed aid for the US government, but Trump claimed its expenditure was "wasteful" and his administration was seeking direct bilateral deals to boost transparency and responsibility.
Based on statements, Sixteen nations in Africa have so far signed these new agreements, constituting more than $18.3bn of fresh investment.
Details of the Declined Deal
This assistance for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation might have yielded extraordinary advantages for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy through US-supported initiatives," Tremont commented.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"Our nation was requested to surrender its genetic material and health information for a long time, with no corresponding guarantee of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that shared data," Mangwana explained.
"Effectively, our country would supply the raw materials for medical research with no assurance that the final treatments would be available to our population if a future health crisis arise."
Sovereignty and International Frameworks
Mangwana further pointed out that the American exit from the global health body and its push of bilateral deals were upending structures already established via the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to deal with potential pandemics.
"This system is intended to ensure that when a nation provides its information, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised solely by those with the capability to develop them."
These objections over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We are open to further discussions with our American counterparts on how subsequent collaboration could be designed in a manner that honours the sovereignty and dignity of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the official position, but suggested that negotiations need to persist given that a large portion of the country's Aids initiatives were funded by external financing.
"Where technical issues exist, such as those involving data governance or implementation frameworks, these can often be resolved through technical clarification and negotiated safeguards," the group said.
This impasse highlights the continuing tensions between receiving much-needed international aid and safeguarding local interests in an increasingly interconnected world.